{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:13:17Z","timestamp":1778793197609,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.pcl.2013.11.006","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T16:48:23Z","timestamp":1388767703000},"page":"309-319","source":"Crossref","is-referenced-by-count":20,"title":["Diagnosis and Management of Morphea and Lichen Sclerosus and Atrophicus in Children"],"prefix":"10.1016","volume":"61","author":[{"given":"Elena","family":"Pope","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald M.","family":"Laxer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcl.2013.11.006_bib1","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmsted County 1960\u20131993","volume":"24","author":"Peterson","year":"1997","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.pcl.2013.11.006_bib2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","article-title":"Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study","volume":"45","author":"Zulian","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pcl.2013.11.006_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","article-title":"Pediatric morphea (localized scleroderma): review of 136 patients","volume":"59","author":"Christen-Zaech","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.006_bib4","first-page":"S36","article-title":"Localized and systemic forms of scleroderma in adults and children","volume":"24","author":"Atzeni","year":"2006","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.pcl.2013.11.006_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1067\/mjd.2001.113474","article-title":"Childhood vulvar lichen sclerosus: an increasingly common problem","volume":"44","author":"Powell","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.006_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1529-8019.2012.01479.x","article-title":"Localized scleroderma","volume":"25","author":"Kreuter","year":"2012","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.pcl.2013.11.006_bib7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archdermatol.2009.79","article-title":"Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases","volume":"145","author":"Leitenberger","year":"2009","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.pcl.2013.11.006_bib8","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jamadermatol.2013.4207","article-title":"Morphea in adults and children cohort III: nested case\u2013control study\u2014the clinical significance of autoantibodies in morphea","volume":"149","author":"Warner Dharamsi","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.pcl.2013.11.006_bib9","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","article-title":"Localized scleroderma","volume":"18","author":"Laxer","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.pcl.2013.11.006_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1365-2133.2000.03360.x","article-title":"Lichen sclerosus premenarche: autoimmunity and immunogenetics","volume":"142","author":"Powell","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.006_bib11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11926-012-0308-9","article-title":"Recent developments in diagnosis and assessment of morphea","volume":"15","author":"Nouri","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.pcl.2013.11.006_bib12","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaad.2010.09.006","article-title":"A\u00a0systematic review of morphea treatments and therapeutic algorithm","volume":"65","author":"Zwischenberger","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.006_bib13","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jaad.2012.01.011","article-title":"Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment","volume":"67","author":"Johnson","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.006_bib14","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4065\/70.11.1068","article-title":"Classification of morphea (localized scleroderma)","volume":"70","author":"Peterson","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pcl.2013.11.006_bib15","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamadermatol.2013.5079","article-title":"Morphea (localized scleroderma)","volume":"149","author":"Fett","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.pcl.2013.11.006_bib16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0049-0172(94)90028-0","article-title":"Localized scleroderma in childhood: a report of 30 cases","volume":"23","author":"Uziel","year":"1994","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.pcl.2013.11.006_bib17","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jaad.2012.04.003","article-title":"Coexistence of lichen sclerosus and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center","volume":"67","author":"Kreuter","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.006_bib18","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized scleroderma in childhood is not just a skin disease","volume":"52","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2013.11.006_bib19","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1111\/j.1468-3083.2012.04581.x","article-title":"Clinicopathological study of 81 cases of localized and systemic scleroderma","volume":"27","author":"Succaria","year":"2013","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.pcl.2013.11.006_bib20","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/ard.62.8.771","article-title":"Antiphospholipid antibody in localised scleroderma","volume":"62","author":"Sato","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pcl.2013.11.006_bib21","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/art.1780370618","article-title":"Serum levels of soluble interleukin-2 receptor. A marker of disease activity in localized scleroderma","volume":"37","author":"Uziel","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2013.11.006_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000071783","article-title":"Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma","volume":"207","author":"Hasegawa","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.pcl.2013.11.006_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0190-9622(98)70077-5","article-title":"Topical calcipotriene for morphea\/linear scleroderma","volume":"39","author":"Cunningham","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.006_bib24","first-page":"14","article-title":"Generalized morphea successfully treated with tacrolimus 0.1% ointment","volume":"12","author":"Cantisani","year":"2013","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.pcl.2013.11.006_bib25","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s10227-001-0134-6","article-title":"Imiquimod: a review","volume":"6","author":"Gupta","year":"2002","journal-title":"J\u00a0Cutan Med Surg"},{"key":"10.1016\/j.pcl.2013.11.006_bib26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000335560","article-title":"Topical imiquimod 5% cream for pediatric plaque morphea: a prospective, multiple-baseline, open-label pilot study","volume":"223","author":"Pope","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.pcl.2013.11.006_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2133.2009.09438.x","article-title":"Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study","volume":"162","author":"Andres","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.006_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1346-8138.2009.00750.x","article-title":"Case of localized scleroderma successfully treated with bath psoralen and ultraviolet A therapy","volume":"37","author":"Uchiyama","year":"2010","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.pcl.2013.11.006_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/phpp.12063","article-title":"Bath psoralen-UVA photochemotherapy for localized scleroderma: experience from a single institute","volume":"29","author":"Pavlotsky","year":"2013","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.pcl.2013.11.006_bib30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jaad.2012.02.044","article-title":"Systematic review and meta-analysis of randomized controlled trials on topical interventions for genital lichen sclerosus","volume":"67","author":"Chi","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.006_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3476(00)90056-8","article-title":"Methotrexate and corticosteroid therapy for pediatric localized scleroderma","volume":"136","author":"Uziel","year":"2000","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2013.11.006_bib32","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.30264","article-title":"Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial","volume":"63","author":"Zulian","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2013.11.006_bib33","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2012.03.036","article-title":"A\u00a0long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea)","volume":"67","author":"Zulian","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.006_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5070\/D383K6X3TB","article-title":"Familial linear scleroderma (en coup de sabre) responsive to antimalarials and narrowband ultraviolet B therapy","volume":"13","author":"Brownell","year":"2007","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.pcl.2013.11.006_bib35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1525-1470.2008.00848.x","article-title":"Rapid response to cyclosporine and maintenance with methotrexate in linear scleroderma in a young girl","volume":"26","author":"Perez Crespo","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.pcl.2013.11.006_bib36","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/rheumatology\/kep244","article-title":"Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil","volume":"48","author":"Martini","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pcl.2013.11.006_bib37","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/acr.21687","article-title":"Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma","volume":"64","author":"Li","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.pcl.2013.11.006_bib38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2133.2011.10535.x","article-title":"Relapse after systemic treatment in paediatric morphoea","volume":"166","author":"Mirsky","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.006_bib39","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.3899\/jrheum.100062","article-title":"En coup de sabre scleroderma and Parry-Romberg syndrome in adolescents: surgical options and patient-related outcomes","volume":"37","author":"Palmero","year":"2010","journal-title":"J\u00a0Rheumatol"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395513002095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395513002095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T14:11:48Z","timestamp":1716387108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395513002095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0031395513002095"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2013.11.006","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}